BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29454624)

  • 1. The Synergetic Effects of Nonpolar and Polar Protic Solvents on the Properties of Felodipine and Soluplus in Solutions, Casting Films, and Spray-Dried Solid Dispersions.
    Chen Y; Huang W; Chen J; Wang H; Zhang S; Xiong S
    J Pharm Sci; 2018 Jun; 107(6):1615-1623. PubMed ID: 29454624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
    Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
    J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
    Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
    Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.
    Lu J; Cuellar K; Hammer NI; Jo S; Gryczke A; Kolter K; Langley N; Repka MA
    Drug Dev Ind Pharm; 2016; 42(3):485-96. PubMed ID: 26530290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
    Dontireddy R; Crean AM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
    Ousset A; Bassand C; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
    Pharm Dev Technol; 2019 Jun; 24(5):560-574. PubMed ID: 30303440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
    Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
    Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations.
    Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T
    Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
    Shamma R; Elkasabgy N
    Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
    Lavra ZM; Pereira de Santana D; Ré MI
    Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of solvent composition on the miscibility and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-drying.
    Paudel A; Van den Mooter G
    Pharm Res; 2012 Jan; 29(1):251-70. PubMed ID: 21773852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
    Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
    Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
    Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
    Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
    Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray-dried solid dispersions containing ferulic acid: comparative analysis of three carriers, in vitro dissolution, antioxidant potential and in vivo anti-platelet effect.
    Nadal JM; Gomes ML; Borsato DM; Almeida MA; Barboza FM; Zawadzki SF; Farago PV; Zanin SM
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1813-24. PubMed ID: 27032626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.